Company projects $35 million in second-half revenue and expands into scalp care while navigating inventory costing issues.

Solesence expands its scalp care portfolio with a barrier-repair serum and SPF 45+ dry shampoo powered by patented technologies for hydration, oil control and UV protection.

Solesence Inc (SLSN) reports a revenue dip but remains optimistic about future growth through new technologies and improved operational strategies.

Moby summary of Solesence, Inc. Common Stock's Q1 2026 earnings call

Solésence reported improved gross margin in the first quarter despite lower revenue and a return to a net loss, as the company continued executing its Transform & Transcend strategic initiative. Key Investor TakeawaysSolésence (NASDAQ:SLSN) posted first-quarter revenue of $13.

Discover why Zacks issues an "Underperform" rating for Solesence, being the first on Wall Street to initiate coverage on the stock. Learn how margin pressure, cash flow weakness, rising leverage and execution challenges are weighing on growth.

Moby summary of Solesence, Inc. Common Stock's Q4 2025 earnings call

Solesence Inc (SLSN) reports a significant turnaround with record annual revenue and improved margins, while outlining ambitious plans for future growth.

Solesence Inc (SLSN) faces revenue and margin pressures but remains optimistic about future growth through strategic reorganization and innovation.